Immunophotonics Announces Research Collaboration to Study Combination of Its Lead Asset with Radiotherapy
SAINT LOUIS, MISSOURI, USA, December 21, 2023 /EINPresswire.com/ -- Immunophotonics, Inc., a clinical-stage biotech company focused on the discovery and development of novel immune-activating drugs, has announced a research collaboration with Johnson …